MYOS RENS Technology, Inc. (NASDAQ: MYOS), a company based in Cedar Knolls, NJ was founded in 2011 to develop and market innovative advanced nutrition products for addressing muscle health in humans and domestic pets. Our products are all natural, safe and effective and backed by rigorous scientific research. We collaborate with commercial and academic institutes such as German Institute of Food Technology, Rutgers University, University of California at Berkeley, Kansas State University, University of Arkansas for Medical Sciences and University of Tampa to conduct research and clinical trials which support our products. Research has demonstrated that improved muscle health is associated with improved longevity, better quality of life and better outcomes for many serious illnesses. Within human muscle health, our company addresses three core market segments: sports nutrition, healthy aging and rehabilitation & recovery. Our domestic pet division is focused on canine muscle health. MYOS has a strong intellectual property portfolio with multiple patents and patent applications which protect our products and technologies. MYOSâ products YolkedÂŽ and Myos Canine Muscle FormulaÂŽ powered by FortetropinÂŽ are sold direct-to-consumer (www.yolked.com and www.Myospet.com), on Amazon and at The Vitamin Shoppe. The current senior management team is comprised of accomplished leaders with backgrounds in Finance, Scientific Research and Engineering with experience in industries such as Investment Banking, Pharmaceuticals and Biotechnology. Source
No articles found.
ProLung is a medical technology company specializing in innovative predictive anal...
ProLung is a medical technology company special...
Global Cancer Technology was formed to acquire a portfolio of various medical lice...
Global Cancer Technology was formed to acquire ...
Mustang Bio, Inc. (âMustangâ), a Fortress Biotech Company, is a clinical-stage...
Mustang Bio, Inc. (âMustangâ), a Fortress B...
Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceut...
Hutchison China MediTech Limited, known as Chi-...
Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...
Neurocarrus is developing a breakthrough therap...
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...
Concert Pharmaceuticals is a clinical stage bio...
Since Mannatechâs establishment in 1994, the company has pioneered a commitment ...
Since Mannatechâs establishment in 1994, the ...
Join the National Investor Network and get the latest information with your interests in mind.